Cargando…

Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial

PURPOSE: Increased body mass index (BMI) has been associated with poor outcomes in women with breast cancer. We evaluated the association between BMI and pathological complete response (pCR) in the I-SPY 2 trial. METHODS: 978 patientsenrolled in the I-SPY 2 trial 3/2010–11/2016 and had a recorded ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haiyun, Yee, Douglas, Potter, David, Jewett, Patricia, Yau, Christina, Beckwith, Heather, Watson, Allison, O’Grady, Nicholas, Wilson, Amy, Brain, Susie, Pohlmann, Paula, Blaes, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312926/ https://www.ncbi.nlm.nih.gov/pubmed/37397981 http://dx.doi.org/10.21203/rs.3.rs-2588168/v1

Ejemplares similares

Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL
por: Olshen, Adam, et al.
Publicado: (2017)

Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial
por: Onishi, Natsuko, et al.
Publicado: (2020)

Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment
por: Blaes, Anne, et al.
Publicado: (2015)

Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial
por: Wolf, Denise M., et al.
Publicado: (2020)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time
por: Shaaban, Adnan, et al.
Publicado: (2023)

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657)
por: Clark, Amy S, et al.
Publicado: (2014)

Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer
por: Hu, Shen-Bao, et al.
Publicado: (2019)

Neoadjuvant chemotherapy and pathologic response: a retrospective cohort
por: de Andrade, Diocésio Alves Pinto, et al.
Publicado: (2013)

Translation and validation of the Simplified Psoriasis Index (SPI) into Brazilian Portuguese
por: de Morais, Marina Resener, et al.
Publicado: (2018)

SpiNNTools: The Execution Engine for the SpiNNaker Platform
por: Rowley, Andrew G. D., et al.
Publicado: (2019)

Mammographic and Ultrasonographic Imaging Analysis for Neoadjuvant Chemotherapy Evaluation: Volume Reduction Indexes That Correlate With Pathological Complete Response
por: Mello, Juliana M, et al.
Publicado: (2022)

Spy&Go purification of SpyTag-proteins using pseudo-SpyCatcher to access an oligomerization toolbox
por: Khairil Anuar, Irsyad N. A., et al.
Publicado: (2019)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Esserman, Laura J., et al.
Publicado: (2011)

Spying on the environment.
Publicado: (1995)

The virus spy
por: Hoag, Hannah
Publicado: (2009)

Catching a SPY: Using the SpyCatcher-SpyTag and Related Systems for Labeling and Localizing Bacterial Proteins
por: Hatlem, Daniel, et al.
Publicado: (2019)

SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology
por: Kellmann, Sarah-Jane, et al.
Publicado: (2023)

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial
por: Parker, Barbara A., et al.
Publicado: (2023)

A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
por: Herrero-Vicent, C, et al.
Publicado: (2016)

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
por: Dong, Jie, et al.
Publicado: (2021)

Development of SpyTag/SpyCatcher-Bacmid Expression Vector System (SpyBEVS) for Protein Bioconjugations Inside of Silkworms
por: Xu, Jian, et al.
Publicado: (2019)

Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic
por: Thomaier, Lauren, et al.
Publicado: (2020)

SpyTag/SpyCatcher Cyclization Enhances the Thermostability of Firefly Luciferase
por: Si, Meng, et al.
Publicado: (2016)

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL
por: Li, Wen, et al.
Publicado: (2016)

A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
por: Kunnuru, Supreeth Kumar Reddy, et al.
Publicado: (2020)

The spy that went into the cold
Publicado: (1998)

Five spy novels
Publicado: (1962)

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2(+) breast cancer in the adaptively randomized I-SPY2 trial
por: Clark, Amy S., et al.
Publicado: (2021)

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
por: Severson, Tesa M., et al.
Publicado: (2017)

Evolving Accelerated Amidation by SpyTag/SpyCatcher to Analyze Membrane Dynamics
por: Keeble, Anthony H., et al.
Publicado: (2017)

Surface Display of Complex Enzymes by in Situ SpyCatcher‐SpyTag Interaction
por: Gallus, Sabrina, et al.
Publicado: (2020)

One-step construction of circularized nanodiscs using SpyCatcher-SpyTag
por: Zhang, Shanwen, et al.
Publicado: (2021)

Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL
por: Li, Wen, et al.
Publicado: (2020)

Tuning SpyTag–SpyCatcher mutant pairs toward orthogonal reactivity encryption
por: Liu, Yajie, et al.
Publicado: (2017)

Spy vs. spy: selecting the best reporter for (19)F NMR competition experiments
por: de Castro, Guilherme Vieira, et al.
Publicado: (2019)

The Cell Wall Deacetylases Spy1094 and Spy1370 Contribute to Streptococcus pyogenes Virulence
por: Aspell, Tiger, et al.
Publicado: (2023)

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
por: Jones, R L, et al.
Publicado: (2006)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
por: An, Ji Yeong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p70f7tfq91n0gt2n015dmnbpb7